InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| NF-κB and NLRP3 inflammasome inhibitor - BAY 11-7082 | Innate Immune Training of Human Macrophages by Cathelicidin Analogs. | 2022 | Front Immunol. | Van Dijk A. et al. | DOI: 10.3389/fimmu.2022.777530 |
| LPS-EB (LPS from E. coli O111:B4) | Innate Immune Training of Human Macrophages by Cathelicidin Analogs. | 2022 | Front Immunol. | Van Dijk A. et al. | DOI: 10.3389/fimmu.2022.777530 |
| SB203580 | Innate Immune Training of Human Macrophages by Cathelicidin Analogs. | 2022 | Front Immunol. | Van Dijk A. et al. | DOI: 10.3389/fimmu.2022.777530 |
| Pam3CSK4 | Innate Immune Training of Human Macrophages by Cathelicidin Analogs. | 2022 | Front Immunol. | Van Dijk A. et al. | DOI: 10.3389/fimmu.2022.777530 |
| LPS-SM Ultrapure (LPS from S. minnesota R595) | Innate Immune Training of Human Macrophages by Cathelicidin Analogs. | 2022 | Front Immunol. | Van Dijk A. et al. | DOI: 10.3389/fimmu.2022.777530 |
| Pam2CSK4 | Innate Immune Training of Human Macrophages by Cathelicidin Analogs. | 2022 | Front Immunol. | Van Dijk A. et al. | DOI: 10.3389/fimmu.2022.777530 |
| c-di-GMP Fluorinated | Identification of Cyclic-di-GMP-Modulating Protein Residues by Bidirectionall... | 2022 | mSystems | Collin Kessler C. & Kim W. | DOI: 10.1128/msystems.00737-22 |
| OVA peptides | GAB functions as a bioenergetic and signalling gatekeeper to control T cell i... | 2022 | Nat Metab | Kang S. et al. | DOI: 10.1038/s42255-022-00638-1 |
| CFA | GAB functions as a bioenergetic and signalling gatekeeper to control T cell i... | 2022 | Nat Metab | Kang S. et al. | DOI: 10.1038/s42255-022-00638-1 |
| Blasticidin | Monitoring autochthonous lung tumors induced by somatic CRISPR gene editing i... | 2022 | Mol Cancer | Merle N. et al. | DOI: 10.1186/s12943-022-01661-2 |
| HKEB | A new antimicrobial peptide, Pentatomicin, from the stinkbug Plautia stali. | 2022 | Sci Rep. | Nishide Y. et al. | DOI: 10.1038/s41598-022-20427-w |
| Alhydrogel® adjuvant 2% | The SLC26A9 inhibitor S9-A13 provides no evidence for a role of SLC26A9 in ai... | 2022 | FASEB J. | Jo S. et al. | DOI: 10.1096/fj.202200313RR |
| Blasticidin | FGFR redundancy limits the efficacy of FGFR4-selective inhibitors in hepatoce... | 2022 | PNAS | Tao Z. et al. | DOI: 10.1073/pnas.2208844119 |
| Puromycin | FGFR redundancy limits the efficacy of FGFR4-selective inhibitors in hepatoce... | 2022 | PNAS | Tao Z. et al. | DOI: 10.1073/pnas.2208844119 |
| Blasticidin | Diastereomeric Resolution Yields Highly Potent Inhibitor of SARS-CoV-2 Main P... | 2022 | J Med Chem. | Cooper M.S. et al. | DOI: 10.1021/acs.jmedchem.2c01131 |
| Zeocin® | Diastereomeric Resolution Yields Highly Potent Inhibitor of SARS-CoV-2 Main P... | 2022 | J Med Chem. | Cooper M.S. et al. | DOI: 10.1021/acs.jmedchem.2c01131 |
| Hygromycin B Gold | Diastereomeric Resolution Yields Highly Potent Inhibitor of SARS-CoV-2 Main P... | 2022 | J Med Chem. | Cooper M.S. et al. | DOI: 10.1021/acs.jmedchem.2c01131 |
| A549-Dual™ Cells for SARS-CoV-2 studies | Diastereomeric Resolution Yields Highly Potent Inhibitor of SARS-CoV-2 Main P... | 2022 | J Med Chem. | Cooper M.S. et al. | DOI: 10.1021/acs.jmedchem.2c01131 |
| Puromycin | Diastereomeric Resolution Yields Highly Potent Inhibitor of SARS-CoV-2 Main P... | 2022 | J Med Chem. | Cooper M.S. et al. | DOI: 10.1021/acs.jmedchem.2c01131 |
| Primocin® | Formulation of Lipid-Free Polymeric Mesoscale Nanoparticles Encapsulating mRNA. | 2022 | Pharm Res. | Skelton R. et al. | DOI: 10.1007/s11095-022-03398-5 |